$NASDAQ:SNDX

Syndax Pharmaceuticals Intrinsic Value – Syndax Pharmaceuticals Announces Modification of Security Holder Rights
Gallery

Syndax Pharmaceuticals Intrinsic Value – Syndax Pharmaceuticals Announces Modification of Security Holder Rights

☀️Trending News Syndax Pharmaceuticals ($NASDAQ:SNDX) announces modifications to the rights of security holders as per their Form 8-K filing. Syndax [...]

By GoodWhale|June 19, 2023|Categories: Biotechnology, Intrinsic Value|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharmaceuticals Intrinsic Value Calculation – Syndax Pharmaceuticals Harnesses Precision Oncology with Financial Strength, Research & Development
Gallery

Syndax Pharmaceuticals Intrinsic Value Calculation – Syndax Pharmaceuticals Harnesses Precision Oncology with Financial Strength, Research & Development

☀️Trending News Syndax Pharmaceuticals ($NASDAQ:SNDX) is a biopharmaceutical company that is focused on harnessing the power of precision oncology to [...]

By GoodWhale|June 12, 2023|Categories: Biotechnology, Intrinsic Value|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharmaceuticals Reports Q4 GAAP EPS of -$0.62, Beating Expectations by $0.04.
Gallery

Syndax Pharmaceuticals Reports Q4 GAAP EPS of -$0.62, Beating Expectations by $0.04.

Trending News 🌧️ As of December 31, 2022, Syndax Pharmaceuticals ($NASDAQ:SNDX) had approximately $481.3 million in cash, cash equivalents, short-term [...]

By GoodWhale|March 3, 2023|Categories: Biotechnology|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharmaceuticals Gains 0.98%, But Still Lags Market.
Gallery

Syndax Pharmaceuticals Gains 0.98%, But Still Lags Market.

Trending News 🌧️ Syndax Pharmaceuticals ($NASDAQ:SNDX) is a biopharmaceutical company specializing in the development of cancer therapeutics. The company’s stock [...]

By GoodWhale|February 3, 2023|Categories: Biotechnology|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharmaceuticals Intrinsic Stock Value – Syndax Pharmaceuticals Sees Loss Despite Market Gains, Here’s What You Should Know
Gallery

Syndax Pharmaceuticals Intrinsic Stock Value – Syndax Pharmaceuticals Sees Loss Despite Market Gains, Here’s What You Should Know

Trending News 🌧️ Syndax Pharmaceuticals Intrinsic Stock Value - Syndax Pharmaceuticals ($NASDAQ:SNDX), a biopharmaceutical company based in the United States, [...]

By GoodWhale|January 30, 2023|Categories: Biotechnology, Intrinsic Value, Market Forecasts|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharmaceuticals Intrinsic Value – Pierre Legault Sells 24000 Shares of Syndax Pharmaceuticals, Stock
Gallery

Syndax Pharmaceuticals Intrinsic Value – Pierre Legault Sells 24000 Shares of Syndax Pharmaceuticals, Stock

Trending News ☀️ Syndax Pharmaceuticals Intrinsic Value - Syndax Pharmaceuticals ($NASDAQ:SNDX), Inc. is a biopharmaceutical company focused on the development [...]

By GoodWhale|January 28, 2023|Categories: Biotechnology, Intrinsic Value|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Analysts Shed Light on Syndax Pharmaceuticals’ Future Progress
Gallery

Analysts Shed Light on Syndax Pharmaceuticals’ Future Progress

Trending News ☀️ Syndax Pharmaceuticals ($NASDAQ:SNDX) Inc. is a biopharmaceutical company focused on developing therapies for cancer and other diseases. [...]

By GoodWhale|January 7, 2023|Categories: Biotechnology|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Invest in Syndax Pharmaceuticals for Steady High Stock Prices
Gallery

Invest in Syndax Pharmaceuticals for Steady High Stock Prices

Trending News 🌥️ Syndax Pharmaceuticals ($NASDAQ:SNDX) is a biopharmaceutical company based in Waltham, Massachusetts. It is focused on developing treatments [...]

By GoodWhale|December 27, 2022|Categories: Biotechnology, Market Price|Tags: $NASDAQ:SNDX, Biotechnology, NASDAQ|0 Comments

Syndax Pharma’s stock prices jump 4% after FDA grants Breakthrough Therapy Designation for revumenib

Trending News ☀️ Syndax Pharmaceuticals ($NASDAQ:SNDX) is a biopharmaceutical company that focuses on developing targeted small molecule drugs for the [...]